- Home
- ACHC vs ASND Comparison
ACHC vs ASND Comparison
Compare ACHC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHC
- ASND
- Stock Information
- Founded
- ACHC 2005
- ASND 2006
- Country
- ACHC United States
- ASND Denmark
- Employees
- ACHC N/A
- ASND N/A
- Industry
- ACHC Medical Specialities
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ACHC Health Care
- ASND Health Care
- Exchange
- ACHC Nasdaq
- ASND Nasdaq
- Market Cap
- ACHC 6.9B
- ASND 7.7B
- IPO Year
- ACHC N/A
- ASND 2015
- Fundamental
- Price
- ACHC $39.65
- ASND $152.43
- Analyst Decision
- ACHC Strong Buy
- ASND Strong Buy
- Analyst Count
- ACHC 9
- ASND 14
- Target Price
- ACHC $69.00
- ASND $197.36
- AVG Volume (30 Days)
- ACHC 959.3K
- ASND 519.7K
- Earning Date
- ACHC 02-27-2025
- ASND 02-12-2025
- Dividend Yield
- ACHC N/A
- ASND N/A
- EPS Growth
- ACHC N/A
- ASND N/A
- EPS
- ACHC 3.05
- ASND N/A
- Revenue
- ACHC $3,122,525,000.00
- ASND $376,478,932.00
- Revenue This Year
- ACHC $10.05
- ASND $47.51
- Revenue Next Year
- ACHC $9.06
- ASND $88.30
- P/E Ratio
- ACHC $13.01
- ASND N/A
- Revenue Growth
- ACHC 9.13
- ASND 36.34
- 52 Week Low
- ACHC $36.50
- ASND $111.09
- 52 Week High
- ACHC $87.77
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- ACHC 33.80
- ASND 66.26
- Support Level
- ACHC $40.88
- ASND $118.03
- Resistance Level
- ACHC $41.64
- ASND $157.37
- Average True Range (ATR)
- ACHC 1.29
- ASND 6.50
- MACD
- ACHC -0.44
- ASND 3.62
- Stochastic Oscillator
- ACHC 1.44
- ASND 87.44
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.